Witt PL - Search Results

1

Interferon alpha enhances expression of TAG-72 and carcinoembryonic antigen in patients with primary colorectal cancer.

Mahvi DM, Madsen JA, Witt PL, Sondel PM. Mahvi DM, et al. Among authors: witt pl. Cancer Immunol Immunother. 1995 May;40(5):311-4. doi: 10.1007/BF01519631. Cancer Immunol Immunother. 1995. PMID: 7600563 Free PMC article.

2

Immunological effects of levamisole in vitro.

Schiller JH, Lindstrom M, Witt PL, Hank JA, Mahvi D, Wagner RJ, Sondel P, Borden EC. Schiller JH, et al. Among authors: witt pl. J Immunother (1991). 1991 Oct;10(5):297-306. doi: 10.1097/00002371-199110000-00001. J Immunother (1991). 1991. PMID: 1790137

3

Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factor.

Schiller JH, Witt PL, Storer B, Alberti D, Tombes MB, Arzoomanian R, Brown RR, Proctor RA, Voss SD, Spriggs DR, et al. Schiller JH, et al. Among authors: witt pl. Cancer. 1992 Jan 15;69(2):562-71. doi: 10.1002/1097-0142(19920115)69:2<562::aid-cncr2820690247>3.0.co;2-0. Cancer. 1992. PMID: 1728387 Clinical Trial.

4

Phase I trial of an oral immunomodulator and interferon inducer in cancer patients.

Witt PL, Ritch PS, Reding D, McAuliffe TL, Westrick L, Grossberg SE, Borden EC. Witt PL, et al. Cancer Res. 1993 Nov 1;53(21):5176-80. Cancer Res. 1993. PMID: 8221654 Clinical Trial.

5

Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly.

Schiller JH, Storer BE, Witt PL, Alberti D, Tombes MB, Arzoomanian R, Proctor RA, McCarthy D, Brown RR, Voss SD, et al. Schiller JH, et al. Among authors: witt pl. Cancer Res. 1991 Mar 15;51(6):1651-8. Cancer Res. 1991. PMID: 1998956 Clinical Trial.

6

Effects of type I and II interferons on cultured human breast cells: interaction with estrogen receptors and with tamoxifen.

Goldstein D, Bushmeyer SM, Witt PL, Jordan VC, Borden EC. Goldstein D, et al. Among authors: witt pl. Cancer Res. 1989 May 15;49(10):2698-702. Cancer Res. 1989. PMID: 2469536

7

Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-beta.

Witt PL, Storer BE, Bryan GT, Brown RR, Flashner M, Larocca AT, Colby CB, Borden EC. Witt PL, et al. J Immunother Emphasis Tumor Immunol. 1993 Apr;13(3):191-200. doi: 10.1097/00002371-199304000-00006. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8471593

8

2',5'-oligoadenylate synthetase in interferon-alpha- and acyclovir-treated herpes simplex virus-infected cells.

Taylor JL, Witt PL, Irizarry A, Tom P, O'Brien WJ. Taylor JL, et al. Among authors: witt pl. J Interferon Cytokine Res. 1995 Jan;15(1):27-30. doi: 10.1089/jir.1995.15.27. J Interferon Cytokine Res. 1995. PMID: 7648430

9

Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.

Schiller JH, Storer B, Witt PL, Nelson B, Brown RR, Horisberger M, Grossberg S, Borden EC. Schiller JH, et al. Among authors: witt pl. Cancer Res. 1990 Aug 1;50(15):4588-94. Cancer Res. 1990. PMID: 2114942

10

Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.

Witt PL, Spear GT, Helgeson DO, Lindstrom MJ, Smalley RV, Borden EC. Witt PL, et al. J Interferon Res. 1990 Aug;10(4):393-402. doi: 10.1089/jir.1990.10.393. J Interferon Res. 1990. PMID: 2121851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters